Damon Inc. Announces Closing of Upsized $16.5 Million Underwritten Public Offering

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results

Wall Street Set to Open Lower Friday as Investors Look to End Losing Week Streak

Top Premarket Decliners

BRIEF-Damon Inc Prices Public Offering Of 126.9 Million Units At $0.13 Per Unit

Damon Inc. Announces Pricing of Upsized $16.5 Million Underwritten Public Offering

Damon Inc - Prices Public Offering of 126.9 Mln Units at $0.13 per Unit

Damon Inc. Announces Pricing of Upsized $16.5 Million Underwritten Public Offering

BRIEF-Damon Inc Files For Offering Of Up To 92.6 Million Pre-Funded Units - SEC Filing

Damon Inc Files for Offering of up to 92.6 Mln Units, up to 92.6 Mln Pre-Funded Units -SEC Filing

BRIEF-Damon Due To Restatement Adjustments, For 3 Months Ended December 31, 2024 EPS Decreased To $2.33 Per Share

Damon - Due to Restatement Adjustments, for 3 Months Ended December 31, 2024 EPS Decreased to $2.33 per Share

Damon Q4 EPS $2.51 Up From $(2.76) YoY, Sales $49.52K

Damon reports Q2 EPS $2.51 vs ($2.76) last year

Damon Inc - Q2 EPS $2.51

Press Release: Damon Provides Operational Business Update and Reports FY25 Q2 Results

Sinaptica Announces Initiation of Co-Development of the SinaptiStim® Precision Neuromodulation System to treat Alzheimer’s Disease; On Track for Pivotal Clinical Trial Initiation in 2025

Damon Inc - Agreement Includes Pre-Paid Purchases up to $10 Million

Damon Inc - Enters Securities Purchase Agreement With Streeterville Capital